Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
Peter J GoadsbyBarbanti PieroGiorgio LambruAnders EttrupCecilie Laurberg ChristoffersenMette Krog JosiassenRavinder PhulBjørn SperlingPublished in: European journal of neurology (2022)
ClinicalTrials.gov identifier: NCT04418765; EudraCT identifier: 2019-004497-25.